In This Store
Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:Gilteritinib fumarate
CAS No.:1254053-43-4
Standard:In-house Standards
Price(USD):Negotiable
Company:ZF Polpharma S.A.
Grade: Pharmaceutical Grade
Factory Location: EU-Poland
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: yes
Payment Terms: L/C
Gilteritinib fumarate
Status | Pipeline |
Development phase | Initial stage |
Therapeutic cat. | Oncology |
CAS No. | 1254053-43-4 |
OEB No. |
4 |
Drug description
Gilteritinib is an AXL receptor tyrosine kinase inhibitor used to treat relapsed or refractory acute myeloid leukemia.
DISCLAIMER Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: